Latest Mergers And Acquisitions News

Emmerson Resources is set to be acquired by Pan African Resources for approximately A$311 million, offering shareholders a 36% premium. The company also advances a government-backed feasibility study for a shared processing facility and begins royalty revenue inflows.

ACDC Metals (ASX: ADC) has acquired an option to earn full ownership of the Mount Jackson gold-silver project in Nevada’s prolific Walker Lane district, backed by a $0.935 million placement and a planned $1.56 million rights issue to fund exploration.

Forte Energy has rapidly expanded its oil and gas exploration portfolio in Alaska’s National Petroleum Reserve, acquiring over 156,000 acres including the billion-barrel Harrier Prospect and adjacent leases to Umiat Oil Field, while securing significant cost savings through lease fee suspensions.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.

Hawk Resources reports high-grade copper mineralisation at Utah's Cactus project and secures an option to acquire up to 80% of Arizona's Meerkat copper project, while progressing scandium exploration in Western Australia.

Mesoblast Limited posted US$30.3 million in net revenues for Ryoncil® in Q3 2026, hitting key clinical milestones and securing new technology licenses that could boost its next-generation cell therapies.

Freehill Mining’s aggregates business surged with a 59% jump in quarterly sales, while new copper project options promise to shift the company’s growth trajectory.

Strategic Energy Resources (ASX:SER) has locked in a $6 million joint venture with Sumitomo for its Bulimba Gold Project, secured $400,000 in government grants for drilling, and completed capital consolidation, positioning itself for a busy exploration season in Queensland.

Gibb River Diamonds (ASX:GIB) has completed mining and processing at its Neta JV within the Edjudina Gold Project, generating over 5,200 ounces of gold and receiving a $7 million profit share. The company is progressing exploration on a new lease near Neta and maintains a strong cash position to support further growth.

Alterity Therapeutics secures FDA backing on key Phase 3 elements for ATH434 in Multiple System Atrophy, bolstered by fresh Phase 2 data showing slowed disease progression and strategic leadership hires.

archTIS delivered a 231% year-on-year increase in annual recurring revenue to A$15.1 million, marked by the full deployment of its US Department of Defense custom software and a significant contract with a US-European military alliance.

Black Rock Mining is closing in on full construction readiness at its Mahenge Graphite Project after completing key early works and advancing funding discussions amid improving graphite prices.